Neurodiagnostics Market Trends & Opportunities - Industry Analysis 2024
According to the research report neurodiagnostics market is expected to reach USD 8.4 billion by 2024 from USD 5.9 billion in 2019, at a CAGR of 7.3%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=229090425
The
demand for neurodiagnostic products is expected to grow mainly due to
factors such as the increasing prevalence of neurological disorders
& diseases, technological advancements, growing patient emphasis on
effective & early disease diagnosis, the growing number of
diagnostic centers & hospitals, and the use of biomarker profiling
for disease diagnostics. These factors have prompted market players to
improve and strengthen their current manufacturing and distribution
capabilities—especially in emerging markets, which are expected to
witness the highest growth.
In this report, the Neurodiagnostic Technology Market has been segmented based on product, condition, end-user, and region.
North
America accounted for the largest share of the Neurodiagnostic Market,
by region, in 2018, followed by Europe. This can primarily be attributed
to factors such as the high adoption of innovative neurodiagnostic
devices among medical professionals, and full availability of advanced
neurodiagnostic devices.
Based on the product, the
neurodiagnostics market is segmented into diagnostic imaging systems,
clinical diagnostic instruments, and reagents and consumables. The
diagnostic imaging systems segment accounted for the largest share of
the neurodiagnostics technology market in 2018. The increasing incidence
and prevalence of neurological disorders and growing R&D in the
field of cerebral and spinal disorders are the major factors driving the
growth of this segment
The hospitals & surgical centers
segment accounted for the largest share of the neurodiagnostics market,
by end-user, in 2018
On the basis of end-user, the
neurodiagnostics market is segmented into hospitals & surgical
centers, diagnostic laboratories & imaging centers, neurology
centers, ambulatory care centers (ACCs), and research laboratories &
academic institutes.
In 2018, hospitals & surgical centers
accounted for the largest share of the neurodiagnostics technology
market, mainly due to the financial capabilities of hospitals to
purchase expensive equipment, such as neurodiagnostic devices.
Some
of the prominent players in the Neurodiagnostics market include GE
Healthcare (US), Siemens Healthineers (Germany), Philips Healthcare
(Netherlands), Hitachi, Ltd. (Japan), Canon, Inc. (Japan), Lifelines
Neuro Company, LLC (US), Natus Medical Incorporated (US), Hoffman-La
Roche AG (Switzerland), FUJIFILM Holdings Corporation (Japan), Mitsar
Co., Ltd. (Russia), Advanced Brain Monitoring (US), Thermo Fisher
Scientific, Inc. (US), Bio-Rad Laboratories (US), QIAGEN N.V.
(Netherlands), Nihon Kohden Corporation (Japan), ANT Neuro
(Netherlands), Fonar Corporation (US), Fujirebio (Japan), DRG
Instruments GmbH (Germany), Tecan Trading AG (Switzerland), Motion Lab
Systems, Inc. (US), Rigaku Corporation (Japan), Neusoft Medical Systems
Co., Ltd. (US), ELMIKO MEDICAL Sp. Z o.o. (Poland) and Ridge Diagnostics
(US).
Get Report Sample : https://www.marketsandmarkets.com/requestsampleNew.asp?id=229090425
Comments
Post a Comment